Visualase Inc. Selected to Present at Epilepsy Conference

Feb. 23, 2010 - PRLog -- Visualase Inc.  announced today that Bill Hoffman will present an overview of Visualase's MR Guided Focal Therapy Technology at the Epilepsy Pipeline Update 2010 conference, an in-depth, 2-day forum to be held February 25-26, 2010, at the Hyatt Embarcadero Hotel in San Francisco.  The conference will feature a line up of leading innovators, clinical investigators and industry leaders who will offer insights into the discovery and development of pioneering drugs, biologics and devices for epilepsy with the goal of accelerating patient access to new treatments.  Visualase Inc. was selected to present by the Scientific and Business of Advisory Boards of the Epilepsy Therapy Project, a non-profit organization that supports the commercialization of new epilepsy therapies.

The conference will bring together emerging CNS companies and scientific entrepreneurs to present their strategies, product candidates and development programs to potential venture capital, private equity, pharma and biotech investors and partners.  Presenters will cover the most innovative therapies in development today for epilepsy.

# # #

Visualase, Inc. is focused in product development, clinical evaluations, manufacturing, and marketing of advanced image-guided laser technologies for thermal focal ablation markets.

The unprecedented level of precision and control afforded by the Visualase technology has made possible ablation of tissue in highly sensitive areas such as brain and prostate. Doctors are currently using the system for ablation of brain, prostate, liver, bone, and other solid tumors. For more information about the Visualase Technology and Visualase Inc., visit http://www.visualaseinc.com.